[The diagnostic significance of creatine phosphokinase antibodies in the cardiac muscle in non-coronarogenic myocardial diseases].
Complement-binding antibodies to myocardium and cardiospecific enzyme creatine phosphokinase were determined in 25 patients with dilated cardiomyopathy, 29 patients with rheumatic myocarditis and in 21 patients with non-rheumatic myocarditis. The antibodies were shown to have diagnostic and differentiating significance in severe non-coronary heart disease associated with disordered systolic function of the heart.
Amosova
E N
EN
Sidorova
L L
LL
D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis*; D003168:Complement Fixation Tests; D003402:Creatine Kinase / Q000276:immunology*; D003937:Diagnosis, Differential; D006801:Humans; D009205:Myocarditis / Q000175:diagnosis*; D009206:Myocardium / Q000201:enzymology / Q000276:immunology*; D012214:Rheumatic Heart Disease / Q000175:diagnosis
D001323:Autoantibodies; D015415:Biomarkers; D003402:Creatine Kinase
Diagnosticheskoe znachenie antitel k kreatinfosfokinaze v myshtse serdtsa pri nekoronarogennykh zabolevaniiakh miokarda.